Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-19-012056)

Filing Details

Accession Number:: 0001179110-19-012056
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-26 07:50:04
Reporting Period:: 2019-11-25

Accepted Time:: 2019-11-26 07:50:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1130598	Onconova Therapeutics Inc.	ONTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1607714	Patrick Mark Guerin	C/O Onconova Therapeutics, Inc. 375 Pheasant Run Newtown PA 18940	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-25	87,500	$0.20	87,844	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to purchase)	Acquisiton	2019-11-25	87,500	$0.00	87,500	$0.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
87,500	2019-11-25	2024-11-25	No	4	P	Direct

Footnotes

The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20.